Qiagen Faces Near-Term Challenges, but Long-Term Prospects Look Solid

Qiagen aims to help scientists and caregivers use biological samples to identify and solve problems related to DNA, RNA, and proteins, which should remain in demand even as the pandemic transitions into an endemic situation, albeit probably at a lower rate. Qiagen's roots are in products that help scientists prepare biological samples for various experiments, and sample preparation products still accounted for 38% of sales in 2021, although inflated as a percentage of sales due to the COVID-19 health crisis. Qiagen remains a key leader in this niche, and we expect Qiagen to continue to invest to maintain or improve in that business in the long run.